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of response to 10 or 100 nM Iso was higher in HD than LD cells, but the 
kinetics were similar. A β1-AR antagonist (CGP 20712, 100 nM) reduced the 
Iso (100 nM) response in HD but not LD cells. However, a β2-AR antagonist 
(ICI 118551, 5 nM) reduced the response in both conditions. To evaluate 
whether the absence of β1-AR response in LD cells was due to an increased 
PDE activity, we used the non-selective PDE inhibitor IBMX (100 μM). In 
LD cells pretreated with IBMX, the Iso response was maintained even after 
Iso washout, showing that the recovery phase is due to cAMP hydrolysis. 
However, CGP 20712 still did not alter the Iso response. PDE4 inhibition with 
Ro-20-1724 (10 μM) strongly prolonged Iso (10 nM) response in LD and HD 
cells, whereas PDE3 inhibition with cilostamide (1 μM) potentiated Iso 
response in LD cells but had no effect in HD cells, even at a 100 nM Iso 
concentration. We conclude that in HD cells, Iso response involves both β1- 
and β2-AR stimulation and is controlled by PDE4 but not PDE3, whereas in 
LD cells, Iso response involves only β2-AR stimulation and is controlled by 
both PDE3 and PDE4. Thus, β-AR-mediated cAMP signal in vascular SMC 
is strongly dependent on the confluence of the cells.
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β1- and β2-adrenoceptors (β-AR) increase cAMP and activate cAMP-
dependant protein kinase (PKA) to regulate cardiac contraction and gene 
expression. Functional differences between β1-AR and β2-AR stimulations are 
attributed to spatial confinement of β2-AR signalling and differential coupling 
to cAMP degradation by phosphodiesterases (PDEs). Here, we compared β1-
AR and β2-AR activation of PKA in the cytoplasm and the nucleus of adult 
rat ventricular myocytes (ARVMs) using adenovirally encoded A-kinase 
activity reporter (AKAR) based on fluorescence resonance energy transfer 
(FRET) and targeted to these compartments. Isoprenaline (Iso, 10nM) was 
used in combination with the β2-AR antagonist ICI118551 (ICI, 10nM) or 
with the β1-AR antagonist CGP20712A (100nM) for specific β1-AR or β2-AR 
stimulation. β1-AR stimulation strongly activated PKA in both compartments, 
but PKA activation was delayed and reduced in the nucleus (+17±2%, t1/
2on=1,7±0,1 min, n=21) compared to the cytoplasm (+35±2%, t1/2on=0,6±0,1 
min, n=15). β2-AR stimulation induced a small increase in PKA activity only 
in the cytoplasm (+8,8±1%, n=24, p<0.05). β1-AR stimulation with 1 nM Iso 
+ 10nM ICI led to a similar degree of cytoplasmic PKA activation as β2-AR 
stimulation but increased nuclear PKA activity (+3,6±0,5%, n=28, p<0.05). 
PDE3 inhibition with Cilostamide (Cil, 1μM) potentiated PKA activation by 
β1-AR (1 nM Iso) in the cytoplasm and the nucleus, and by β2-AR in the cyto-
plasm, but failed to reveal β2-AR response in the nucleus. PDE4 inhibition 
with Ro-201724 (Ro, 10μM) potentiated β1-AR (1 nM Iso) response in the 
cytoplasm and the nucleus, increased β2-AR responses in the cytoplasm and 
revealed β2-AR dependent nuclear PKA activation. These results show that β1-
AR and β2-AR stimulation differently impact on cytoplasmic and nuclear PKA 
activity and that PDE4 is important to prevent nuclear PKA activation under 
β2-AR stimulation.
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Balance between energy supply and demand is finely tuned in heart. In 
beating heart, intrinsic homeostasis depends on the parallel activation of both 
modules. Here we used the in vitro approach recently introduced in the Insti-
tute (the permeabilized skinned fiber) to study energetics of the four different 
cardiac chambers (right and left atria, right and left ventricles) in order to evi-
dence local differences in the energetics regulation.
Using high-resolution oxygraphy, mitochondrial function was quantified 
and apparent affinities of mitochondrial respiration for added ADP and ATP 
were obtained in absence or not of 25μM-blebbistatin (myosin ATPase inhi-
bitor). Measurement of ATP hydrolysis by spectrofluorometry was also exper-
imented in presence or not of blebbistatin after inhibition of mitochondrial 
oxidative phosphorylation (oligomycin, ATP synthase inhibitor) and respira-
tory chain inhibitor (rotenone).
Apparent affinities of mitochondrial oxidative phosphorylation for ADP 
were significantly higher in ventricles compared to atria. Presence of blebbi-
statin induced a significant increase in the affinity in left atrium, underlining 
the small mitochondrial sensitivity to ADP in the case of myosin ATPase inhi-
bition. Blebbistatin addition under condition of mitochondrial inhibition 
induced a 50% inhibition of ATP hydrolysis in the left ventricle defining an 
interesting specific regulation in this compartment.
We conclude on the hypothesis of different “channeling” mechanisms 
between energy supply and energy demand in each cardiac compartments. Our 
results clearly show a weaker adaptability in energy regulation in the left 
atrium compared to the left ventricle. A model of failing rat heart is now under 
study in order to explore the implication of nucleotide adenylic compartimen-
tation on pathological electric instability.
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